Natural Compounds in the Treatment of Inflammatory lung Diseases: An Approach on Eucalyptol | Chapter 04 | Recent Advances in Biological Research Vol. 4
It is estimated that there will be an
increase in the incidence of chronic obstructive pulmonary disease (COPD) in
the coming decades. Thus, the pharmacological attributes of products of plant
origin should be considered as an important economic and scientific strategy in
the investigation of therapeutic alternatives, since their experimental validations
are indispensable to substantiate the reliability of these products in the
treatment of chronic diseases. Like biologically active compounds, Eucalyptol,
also known as 1,8- cineole, is the major constituent of the leaf oil of
eucalyptus species, such as Eucalyptus globulus and Eucalyptus tereticornis. It
is a terpenoid oxide, free of steroid-like side effects. This study is based on
a review of the specialised literature with purpose to discuss the biological
effects of Eucalyptol in the respiratory system and its interaction with some
of the most promising targets in the treatment of COPD, such as: receivers and
membrane channels, oxidative stress, transcription and expression of cytokines,
cell adhesion molecules and neutrophil chemotaxis, proteases and remodeling.
Author(s) Details
Fladimir de Lima Gondim
Postgraduate Program in
Physiological Sciences, State University of Ceará, Ceará, Brazil.
Gilvan Ribeiro dos Santos
Center of Technological
Sciences, State University of Ceará, Ceará, Brazil.
Daniel Silveira Serra
Center of Technological
Sciences, State University of Ceará, Ceará, Brazil.
Francisco Sales Ávila
Cavalcante
Center of Technological
Sciences, State University of Ceará, Ceará, Brazil.
Comments
Post a Comment